Clinical Trial Update: A Study of the Glaukos Trabecular Micro-Bypass Stent in Refractory Open Angle Glaucoma Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial update indicating completion of the Glaukos Trabecular Micro-Bypass Stent study in refractory open-angle glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• Glaukos Trabecular Micro-Bypass Stent

Snippet

Sponsor: Glaukos Corporation | Conditions: Open-Angle Glaucoma | Phase 4 | Status: COMPLETED